Guanfacine
NDC 70436-039, guanfacine, tablet, extended release, from Slate Run Pharmaceuticals, LLC.
- Product NDC
- 70436-039
- Status
- Listed
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213428
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70436-039 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUANFACINE HYDROCHLORIDE1 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70436-039-01 | 70436003901 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-039-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ed65ca51-b9b0-43b9-9826-03a7be256a2aNADAC price for package 70436003901
GET /v1/drugs/nadac/70436003901
Use it
Look up 70436-039 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70436-039 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70436-039. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.